A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden
{{output}}
Engineered probiotics are an emerging platform for in situ delivery of therapeutics to the gut. Herein, we developed an orally administered, yeast-based therapeutic delivery system to deliver next-generation immune checkpoint inhibitor (ICI) proteins directly ... ...
